Method for early diagnosis of motor-induced muscle micro-injury by using saliva metabolite type biomarker

By detecting specific metabolites in saliva, the problem of difficulty in early diagnosis of motor muscle microinjury in the prior art is solved, and a high sensitivity and specific non-invasive diagnosis is achieved, providing effective exercise health Preventive means.

CN118980810APending Publication Date: 2024-11-19BEIJING INST OF TECH
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411150229.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-21
Publication Date
2024-11-19

AI Technical Summary

Technical Problem

The prior art is difficult to diagnose sports muscle microinjury (EIMD) in an early non-invasive manner, especially in daily mass exercise. Traditional blood biochemical analysis relies on professional equipment and resources and is not suitable for early prevention of health risks caused by high-intensity exercise.

Method used

These markers are used to detect standardized concentrations of specific metabolite-type biomarkers in saliva, including N-n-tetradecyl ammonium, m-adrenaline, phthalic anhydride, hexadecanamide and erucicamide. Early diagnosis.

Benefits of technology

Early diagnosis of motor muscle microinjury is achieved, with the specificity and sensitivity of salivary biomarkers exceeding 80% and 70%, which is better than traditional blood indicators and provides a non-invasive and easy-to-promote diagnostic method.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118980810A_ABST
    Figure CN118980810A_ABST
Patent Text Reader

Abstract

Moving muscle microinjury (EIMD) is the most common health risk in training. At present, EIMD diagnosis depends on blood biochemical analysis and is difficult to popularize and use in public fitness. EIMD early-stage instant diagnosis is expected to be realized by using saliva, but saliva biomarkers of EIMD have not been reported yet. The invention discloses a saliva metabolite type biomarker for early diagnosis of EIMD, which has the sensitivity of more than 70% and the specificity of more than 80%, and has EIMD diagnosis performance better than blood biochemical indexes. Meanwhile, the invention discloses a method for early diagnosis of EIMD by using the saliva metabolite type biomarker, and a basis is provided for establishing a non-invasive EIMD early diagnosis technology.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the field of sports injury detection, and in particular relates to a method for early diagnosis of sports-induced muscle micro-injury using salivary metabolite biomarkers. Background Art

[0002] Exercise is very important for maintaining physical health and preventing chronic diseases. It can effectively improve the sleep quality of adults and reduce the incidence of chronic diseases such as cardiovascular disease and diabetes. The World Health Organization recommends that adults should engage in at least 150-300 minutes of moderate-intensity exercise or at least 75-150 minutes of high-intensity exercise per week. In addition, recent studies have found that short-term high-intensity exercise every day, such as running, fast cycling, basketball and football games, etc. However, high-intensity exercise may also cause health risks, the most common of which is exercise-induced muscle microdamage (EIMD). High-intensity exercise, especially eccentric exercise, will excessively stretch muscle cells, causing the ultrastructure of the sarcomere to be destroyed. At the same time, high-intensity exercise will produce greater metabolic stress, leading to calcium ion overload and accumulation of free radicals, which will also damage and lyse muscle cells. The most typical symptoms of EIMD are muscle pain and loss of strength, which often occur 24 hours after exercise and last for several days, interfering with normal life. At the same time, EIMD is often accompanied by local inflammation and increased recovery period. Severe EIMD can cause rhabdomyolysis, leading to myoglobinuria, hyperkalemia, hypocalcemia, disseminated intravascular coagulation, and the risk of acute renal failure, arrhythmia, microthrombosis, and bleeding. Therefore, early prevention of the occurrence and development of EIMD during high-intensity exercise is of great significance for ensuring sports health.

[0003] At present, the most common method for diagnosing EIMD is blood biochemical index analysis. Creatine Kinase (CK) and lactate dehydrogenase (LDH) in the blood will increase significantly with EIMD, so they are considered to be blood biomarkers reflecting EIMD. At the same time, myoglobin, C-reactive protein, cortisol, and testosterone in the blood are considered to be related to overtraining, which is also prone to EIMD, so they are also used to assist in the diagnosis of EIMD. Blood biochemical analysis has been used to guide athletes in scientific training and scientific recovery, but it is not suitable for daily exercise for the public. This is mainly because blood collection relies on professional technicians and biochemical analyzers, which consumes a lot of precious medical resources. At the same time, blood drawing can also cause physical and psychological discomfort, making it difficult to promote in mass fitness. Recently, some studies have also reported some non-invasive EIMD diagnostic methods. Ultrasound imaging, MRI, OCT, and infrared are used to observe changes in muscle tissue, but they rely on expensive equipment and professional operations. Compared with medical imaging, electromyographic signals are easier to measure and are also related to the occurrence of EIMD, but specific electromyographic indicators have not been reported. EIMD can also be simply diagnosed by pain scale combined with muscle strength assessment, but muscle pain and significant decrease in muscle strength are delayed by 24 hours before the onset of EIMD, which obviously cannot diagnose EIMD early. Therefore, how to diagnose EIMD early non-invasively still needs to be studied.

[0004] Saliva has been used for non-invasive disease diagnosis. Currently, the most common disease diagnosis using saliva is oral disease. A large number of micro RNAs, such as miR-200a and miR-31, can be used to diagnose oral squamous cell carcinoma (OSCC). At the same time, recent studies have found that 25 metabolites in saliva are also potential biomarkers for the diagnosis of OSCC. Metabolites in saliva, such as butyrate, propane-1,2-diol, α-linolenic acid, α-glucose, urea, fumarate, formate, guanosine and purine can be used to diagnose orthodontically induced external apical root resorption, while TLR4 mRNA can be used to diagnose periodontitis. At the same time, recent studies have also reported associations with the occurrence and development of non-oral diseases. For example, compared with normal controls, patients with Parkinson's disease have higher levels of cortisol in their saliva. Patients with lung cancer and prostate cancer have relatively lower levels of prolactin in their saliva. In diabetic patients, a significant increase in salivary amylase levels can be observed. Therefore, recent studies have begun to focus on the use of biomarkers in saliva for disease diagnosis, not limited to oral diseases. Shu et al. reported that fucosylated N- / O-linked glycans are promising biomarkers for gastric cancer, and pepsin in saliva can be used to diagnose gastroesophageal reflux disease and laryngopharyngeal reflux. Considering that saliva contains a variety of disease biomarkers, it is reasonable to assume that saliva may also contain biomarkers for EIMD.

[0005] At present, a series of studies have demonstrated that exercise can cause changes in saliva metabolites. Alzharani et al. found that 2 days of football training led to significant changes in 27 salivary metabolites, of which 22 were upregulated and 5 were downregulated. Ra et al. further revealed the physiological significance of upregulated metabolites. The study found that 3 consecutive days of football matches led to a significant upregulation of 10 metabolites in the saliva of football players. These metabolites were mainly involved in the synthesis and decomposition of glucose and the TCA cycle, which provided support for higher energy metabolism during long-term training. In fact, a short-term high-intensity training can cause significant changes in saliva metabolites. For example, Pitti et al. found that 17 metabolites in saliva changed significantly before and after a football game, of which 14 were upregulated and 3 were downregulated. Moreover, the trend of salivary metabolite changes varies greatly with the training method. Compared with football players, goalkeepers have unique metabolite changes in saliva after the game, including upregulation of formate and downregulation of isocaproate. It is worth noting that goalkeeper training includes quick-response jumping, diving, and falling, which involves more muscle stretching and eccentric movements, suggesting that the differential metabolites in goalkeeper saliva after training may contain markers of EIMD. However, none of these studies analyzed the symptoms of EIMD after exercise, and salivary biomarkers of EIMD have yet to be reported. Summary of the invention

[0006] The present invention reports a method for early diagnosis of exercise-induced muscle microdamage (EIMD) using salivary metabolite biomarkers, the specific contents of which are:

[0007] 1. A method for early diagnosis of EIMD using salivary metabolite biomarkers, characterized in that early diagnosis of EIMD can be achieved by detecting the standardized concentration of salivary metabolite biomarkers of the subject and comparing the detection result with the normal standardized concentration of the biomarker; the salivary metabolite biomarkers include N-tetradecanamide, metanephrine, phthalic anhydride, hexadecanamide and erucamide.

[0008] 2. The method according to claim 1, characterized in that early diagnosis of EIMD can be performed by detecting at least one salivary metabolite-type biomarker.

[0009] 3. The method according to claim 1, characterized in that the salivary metabolite biomarker is derived from saliva.

[0010] 4. The method according to claim 1, wherein the standardized concentration of the salivary metabolite biomarker is calculated by the ratio of the biomarker concentration to the creatinine concentration in the same sample.

[0011] 5. The method according to claim 1, wherein the implementation steps include:

[0012] (1) Collect saliva samples from subjects;

[0013] (2) detecting the standardized concentration of one or more salivary metabolite biomarkers in the sample, including N-tetradecanamide, metanephrine, phthalic anhydride, hexadecanamide, and erucamide;

[0014] (3) Comparing the detected standardized concentration of the salivary metabolite-type biomarker with the normal standardized concentration of the biomarker.

[0015] Compared with previous studies, this patent discloses for the first time a urine metabolite-type biomarker for early diagnosis of EIMD, and also reports a method for early diagnosis of exercise-induced muscle micro-injury using urine metabolite-type biomarkers. BRIEF DESCRIPTION OF THE DRAWINGS

[0016] Figure 1 Changes of serum biochemical indexes in EIMD patients (a: CK; b: LDH)

[0017] Figure 2 Overall changes in salivary metabolites (a: PCA analysis; b: heat map and cluster analysis)

[0018] Figure 3 Analysis of differential metabolites in saliva (a: volcano plot analysis; b: matchstick plot analysis)

[0019] Figure 4 Diagnostic performance of salivary metabolite biomarkers and serum biochemical indicators (a: N-tetradecyl ammonium; b: metanephrine; c: phthalic anhydride; d: hexadecylamide; e: erucamide; f: CK) Specific implementation method

[0020] First, 18 male youths who had no previous regular training experience were recruited through strict inclusion and exclusion criteria. All subjects completed rowing machine training with a resistance value of 30 and a duration of 30 minutes (ethical review number: V20211108). The subjects before training were called Pre-Ex, and those immediately after training were called Immediate Post-Ex. Figure 1 It can be seen that the blood biochemical indicators CK and LDH of the 18 subjects increased significantly after training. Specifically, the CK level increased from 98.11±19.42U / L to 141.17±62.40U / L after training, while LDH increased from 149.83±17.25U / L to 162.78±17.40U / L. The increase in CK and LDH comes from muscle cell rupture and release of endosomes, so CK and LDH are widely considered to be EIMD blood biomarkers. Previous studies have also reported significant increases in CK and LDH when EIMD occurs. For example, Coratella found that after downhill running, CK in the blood increased from 32923±23874pg / mL to 147273±55447pg / mL, accompanied by DOMS and a significant decrease in muscle strength. Fonseca found that after jiu-jitsu training, LDH in the blood increased from 353.0±35.2IU / L to 489.3±40.6IU / L, and DOMS also occurred one day after exercise. According to our survey, all subjects experienced DOMS one day after training. Therefore, the significant increase in blood biomarkers and obvious DOMS together indicate that the subjects experienced EIMD after training.

[0021] In previous studies, resistance training was often used to induce EIMD, while rowing exercise was used to induce EIMD in our study. This is mainly because EIMD is easy to occur in rowing exercise, even for professional rowing athletes. There are four main reasons why the subjects experienced EIMD after training. First, all subjects had never experienced rowing training, and rowing training was unfamiliar to the subjects. At the same time, the maximum resistance of the rowing machine is 32, while the resistance of rowing training in this study was set at 30, which was challenging for the subjects. Second, rowing exercise is a whole-body exercise. Each stretch and release involves muscles throughout the body, of which about 50% of the force comes from the legs, 30% from the trunk, and 20% from the arms. During the release process, the above muscles are in an eccentric contraction state, which is easy to induce more extensive EIMD. Third, rowing training is a repetitive training. In the training plan, the subjects need to complete about 600 stretches and releases. Long-term and high-intensity rowing can easily lead to muscle fatigue and micro-injury. Finally, rowing training combines aerobic and resistance training, and the subjects are at a high level of oxygen consumption rate for a long time, which will accelerate "mitochondrial electron leakage", increase free radical generation and EIMD risk.

[0022] Using targeted metabolomics technology, we analyzed the changes in salivary metabolites of subjects before and after training, and detected 594 metabolites in 36 saliva samples, which is more metabolites than the reported salivary metabolome. Figure 2 The principal component analysis shown in a shows that the three principal components together explain 82.7% of the metabolite changes. It is worth noting that the 18 pre-training samples are clustered in one area, while the 18 post-training samples are clustered in another area. The sample clustering and experimental grouping are consistent, indicating that the salivary metabolites of the subjects have undergone significant changes after training and show similar trends. Moreover, the impact of training on salivary metabolites exceeds the individual differences of the subjects, which is similar to the results of previous studies. Cluster heat map analysis also illustrates this result. Figure 2 As can be seen in the figure, 36 samples were clustered into 2 categories, which is consistent with the experimental grouping of the samples. Moreover, the distribution of the top 25 metabolites was similar within the group, but showed significant differences between the groups. It is worth noting that the change trends of some metabolites were strongly correlated with the changes in CK. It is worth noting that the changes in some metabolites were similar to the change trends of CK and LDH. For example, the correlation coefficient between 9,10-epoxyoctadecadienoic acid (9,10-EODE) and CK reached 0.635, and uric acid had the strongest positive correlation with LDH. So far, the correlation between salivary metabolites and serum biochemical indicators is unclear, and the high correlation may be due to the same mechanical and metabolic stress during exercise.

[0023] Paired T-tests were used to analyze the metabolites that changed significantly in saliva after exercise. The results showed that 67 metabolites changed significantly after exercise, of which 23 metabolites were significantly upregulated and 44 metabolites were significantly downregulated. Previous studies on exercise-induced metabolite changes have reported some metabolite changes. For example, histamine was significantly downregulated after training in this study, and similar phenomena were observed in salivary metabolites of football players after football training in previous studies. In addition, 4-hydroxyphenylpyruvate was significantly upregulated after training, and 4-hydroxyphenylpyruvate was also increased in the saliva of junior professional athletes after football games. In contrast, some changes in salivary metabolites were opposite to the results of previous studies. For example, purine metabolites, including xanthine and hypoxanthine, were significantly downregulated after training, while previous studies found that these purine metabolites were increased in saliva and blood after exercise. The inconsistency of changes in purine metabolites may come from different training times. For example, hypoxanthine was significantly increased after the first day of training, but significantly decreased after the second day of training. Except for the above four metabolites, most of the differential metabolites have not been reported before, because only a few studies have focused on the changes in salivary metabolites induced by exercise. So far, most studies related to exercise metabolomics have only focused on the changes in serum and salivary metabolites. More efforts are urgently needed to deeply explain the effects of common physical exercise on salivary metabolites.

[0024] The pre-exercise group and the immediate post-exercise group, representing subjects without and with EIMD, respectively, were used to evaluate the diagnostic performance of all salivary metabolites and blood biochemical indices. Based on the AUC area ranking, the top five salivary metabolites were N-tetradecanamide, metanephrine, phthalic anhydride, hexadecanamide, and erucamide. The AUC areas of these metabolites in the diagnosis of EIMD all exceeded 0.836, indicating that they have great potential as salivary biomarkers for EIMD. In addition, salivary biomarkers are superior to blood indices in the diagnosis of EIMD. Specifically, the specificity and sensitivity of the five salivary biomarkers exceeded 80% and 70%. However, the specificity and sensitivity of creatine kinase (CK) in diagnosing EIMD were only 80% and 70%, while the specificity and sensitivity of lactate dehydrogenase (LDH) in diagnosing EIMD were also only 80% and 70%. Therefore, these findings suggest that salivary biomarkers have promise in the early diagnosis of EIMD, providing a basis for the prevention of EIMD.

Claims

1. A method for early diagnosis of exercise-induced muscle microdamage (EIMD) using salivary metabolite biomarkers, characterized in that: Early diagnosis of EIMD can be achieved by detecting the standardized concentration of salivary metabolite biomarkers in the subjects and comparing the test results with the normal standardized concentrations of the biomarkers; the salivary metabolite biomarkers include N-tetradecanamide, metanephrine, phthalic anhydride, hexadecanamide and erucamide.

2. The method according to claim 1, characterized in that Early diagnosis of EIMD can be achieved by detecting at least one salivary metabolite-based biomarker.

3. The method according to claim 1, characterized in that The salivary metabolite-type biomarkers are derived from saliva.

4. The method according to claim 1, wherein the standardized concentration of the salivary metabolite biomarker is calculated by the ratio of the biomarker concentration to the creatinine concentration in the same sample.

5. The method according to claim 1, wherein the implementation steps include: (1) Collect saliva samples from subjects; (2) detecting the standardized concentration of one or more salivary metabolite biomarkers in the sample, including N-tetradecanamide, metanephrine, phthalic anhydride, hexadecanamide, and erucamide; (3) Comparing the detected standardized concentration of the salivary metabolite-type biomarker with the normal standardized concentration of the biomarker.